EUVIMEDEUVIMED entdecken
Crossref

Refining neoplasm risk in DICER1-related tumor predisposition

Lisa Golmard, Roseline Vibert, Elise Pierre-Noël, Florian Verrier, Catherine Dubois d'Enghien, Christelle Berthemin, Caroline Abadie, Pascaline Berthet, Laurence Blanc, Valérie Bonadona, Laurence Brugières, Virginie Bubien und 31 weitere

European Journal of Cancer · 2026-11 · 248 · 117765

DOI: 10.1016/j.ejca.2026.117765 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Cancer, 2026-11. Verfasst von Lisa Golmard und 42 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics, Institut Curie, Paris, France; PSL Research University, Paris, France. Electronic address: lisa.golmard@curie.fr. Hauptthemen laut MEDLINE: Ribonuclease III, DEAD-box RNA Helicases, Genetic Predisposition to Disease, Neoplasms. Die Arbeit nennt 19 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: DICER1-related tumor predisposition is an autosomal dominant disorder predisposing to a broad spectrum of malignant and benign neoplasms, caused by germline pathogenic variants (PVs) in the DICER1 gene. We aimed to characterize the clinical features of DICER1-related tumor predisposition in a national referral cohort and to estimate neoplasm risk. MATERIALS AND METHODS: This retrospective study was conducted in a cohort of 945 patients who underwent DICER1 genetic testing at Institut Curie, Paris, using Sanger sequencing from 2012 to 2014 and Next Generation Sequencing from 2015 to 2023. RESULTS: Among 584 index cases evaluated for DICER1-related tumor predisposition, 91 (16%) carried a germline DICER1 PV and 31 (5%) harbored only somatic DICER1 PVs. Several tumors that were not previously part of the DICER1 tumor spectrum were identified. ETMR-like brain tumor and testicular Sertoli cell tumor are now recognized as DICER1-related neoplasms, and schwannoma is a strong candidate. The neoplasm risk was estimated in 170 relatives carrying a germline DICER1 PV. The cumulative incidence of malignant neoplasms was 4.8% [95% CI: 2.1% - 9.1%] at 10 years and 15.8% [95% CI: 8.9% - 24.7%] at 50 years. Overall neoplasm risk was significantly higher in females, primarily driven by the higher incidence of thyroid follicular nodular disease. CONCLUSION: This large cohort study provides a comprehensive overview of the distribution of neoplasms associated with DICER1-related tumor predisposition. Broader genetic testing identified additional DICER1-related neoplasms, and schwannoma emerged as a candidate association. Finally, this study confirms the moderate penetrance of germline DICER1 PVs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ribonuclease IIIDEAD-box RNA HelicasesGenetic Predisposition to DiseaseNeoplasmsHumansFemaleMaleMiddle AgedAdultRetrospective StudiesGerm-Line MutationYoung AdultAdolescentRisk FactorsAgedChildGenetic Testing

Stichwörter der Autor:innen

DICER1 pathogenic variantsDICER1-related tumor predispositionGenetic testingHereditary cancer predispositionNeoplasm riskTumor spectrum

Substanzen

Ribonuclease IIIDEAD-box RNA HelicasesDICER1 protein, human

Autor:innen und Institutionen

  • Department of Genetics, Institut Curie, Paris, France; PSL Research University, Paris, France. Electronic address: lisa.golmard@curie.fr.
  • Department of Genetics, Institut Curie, Paris, France; PSL Research University, Paris, France.
  • Oncogenetic Unit, Institut de Cancérologie de l'Ouest, Saint-Herblain, France.
  • Department of Genetics, Centre François Baclesse, Caen, France.
  • Department of Pediatric Oncology and Hematology, Poitiers University Hospital, Poitiers, France.
  • Prevention and Genetic Epidemiology Unit, Centre Léon Bérard, Lyon, France.

Zitieren

APA

Golmard, L., Vibert, R., Pierre-Noël, E., Verrier, F., Dubois d'Enghien, C., Berthemin, C., Abadie, C., Berthet, P., Blanc, L., Bonadona, V., Brugières, L., Bubien, V., Caron, O., Cogne, M., Collonge-Rame, M. A., Colson, C., Corsini, C., Coupier, I., Crivelli, L., …, & Pasmant, E. (2026). Refining neoplasm risk in DICER1-related tumor predisposition. European Journal of Cancer, 248, 117765. https://doi.org/10.1016/j.ejca.2026.117765

Vancouver

Golmard L, Vibert R, Pierre-Noël E, Verrier F, Dubois d'Enghien C, Berthemin C, et al. Refining neoplasm risk in DICER1-related tumor predisposition. European Journal of Cancer. 2026;248:117765. doi:10.1016/j.ejca.2026.117765

BibTeX
@article{Golmard2026,
  author = {Golmard, Lisa and Vibert, Roseline and Pierre-Noël, Elise and Verrier, Florian and Dubois d'Enghien, Catherine and Berthemin, Christelle and Abadie, Caroline and Berthet, Pascaline and Blanc, Laurence and Bonadona, Valérie and Brugières, Laurence and Bubien, Virginie and Caron, Olivier and Cogne, Muriel and Collonge-Rame, Marie-Agnès and Colson, Cindy and Corsini, Carole and Coupier, Isabelle and Crivelli, Louise and Denizeau, Philippe and Giraud, Sophie and Gourdon, Stéphanie and Guerrini-Rousseau, Léa and Ingster, Olivier and Isidor, Bertrand and Lejeune, Sophie and Mansuy, Ludovic and Mari, Véronique and Mortemousque, Isabelle and Nambot, Sophie and Tinat, Julie and Zattara, Hélène and Bourdeaut, Franck and Orbach, Daniel and Houdayer, Claude and de Pauw, Antoine and Buecher, Bruno and Mouret-Fourme, Emmanuelle and Colas, Chrystelle and Golmard, Jean-Louis and Stoppa-Lyonnet, Dominique and Gauthier-Villars, Marion and Pasmant, Eric},
  title = {Refining neoplasm risk in DICER1-related tumor predisposition},
  journal = {European Journal of Cancer},
  year = {2026},
  volume = {248},
  pages = {117765},
  doi = {10.1016/j.ejca.2026.117765}
}
Kostenlos starten →